Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Molecular and Metabolic Mechanisms of Trypanosoma vivax Vascular Sequestration

Project description

Blocking trypanosome attachment in livestock

Animal African trypanosomiasis is a severe livestock disease caused by trypanosome parasites and transmitted by biting flies. Despite causing major losses in Africa and South America, the most widespread species Trypanosoma vivax remains insufficiently investigated. With the support of the Marie Skłodowska-Curie Actions programme, the VIVASEQ project will investigate how this parasite attaches to blood vessel walls, thereby avoiding clearance and damaging tissues. Researchers will identify the molecules used for attachment, study how the parasite rewires its metabolism to sustain this behaviour, and test ways to block it. Using advanced imaging, metabolomics and vessel-on-chip models, the project could support new disease-control strategies worldwide, with implications for regional livestock health.

Objective

Animal African trypanosomiasis (AAT) is a deadly vector-borne disease of livestock caused by Trypanosoma brucei, T. congolense, and T. vivax. T. vivax is the least studied but the most geographically widespread, driving epidemics across Africa and South America with major economic and social impacts. In the mammalian host, T. vivax exhibits unique vascular tropism through cytoadhesion to endothelial cells (i.e. sequestration), which promotes endothelial activation and tissue pathology. This host–parasite interaction requires both specific adhesion factors and energy to sustain binding under blood flow. Preliminary transcriptomic data from the host lab show that T. vivax undergoes marked transcriptional reprogramming during sequestration, with differential expression of adhesion factors, and upregulation of glycolytic genes, indicating that glucose metabolism supports vascular tropism.
In VIVASEQ, I propose to elucidate the molecular and metabolic mechanisms underlying T. vivax sequestration, with the ultimate goal of functionally disrupting this process, therefore preventing disease. This will be achieved by:
1) identifying the candidate parasite molecules mediating sequestration,
2) characterizing the metabolic remodeling that sustains this interaction, and
3) functionally targeting adhesion factors to disrupt sequestration.
I will apply cutting-edge approaches not yet implemented in T. vivax research, including targeted mass spectrometry, ultrastructural expansion microscopy, metabolomics, and a host-specific vessel-on-chip model. VIVASEQ will provide fundamental knowledge to support the implementation of sequestration-blocking strategies to control AAT, whilst potentially uncovering evolutionarily conserved mechanisms of parasite-endothelial cell interactions with broader relevance to vascular infections.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

UNIVERSIDADE CATOLICA PORTUGUESA
Net EU contribution
€ 191 343,12
Address
PALMA DE CIMA
1649 023 LISBOA
Portugal
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data